NCT04605016

Brief Summary

The aim of the study is to compare longitudinally the clinical performance of dental implants with different surfaces placed in single tooth gaps at the posterior maxilla and mandible of adults. It is a randomized clinical trial, in which participants will be randomly allocated to two groups: test group (implants with hydrophilic surface) and control group (implants with hydrophobic surface). The null hypothesis is that the implant stability quotient of hydrophilic and hydrophobic dental implants show a similar progression after placement in posterior tooth gaps.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
44

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Apr 2021

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

October 15, 2020

Completed
12 days until next milestone

First Posted

Study publicly available on registry

October 27, 2020

Completed
5 months until next milestone

Study Start

First participant enrolled

April 1, 2021

Completed
2.4 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 11, 2023

Completed
4 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 30, 2023

Completed
Last Updated

May 10, 2023

Status Verified

May 1, 2023

Enrollment Period

2.4 years

First QC Date

October 15, 2020

Last Update Submit

May 8, 2023

Conditions

Keywords

single tooth gapmissing tooth

Outcome Measures

Primary Outcomes (1)

  • Change of implant stability

    Implant stability was set as the primary outcome. The implant stability quotient (ISQ) will be measured using a portable device called Osstell ISQ (Osstell Mentor, Integration Diagnostics, Göteborg, Sweden).

    10 time-points will be considered and divided in two phases: surgical and prosthetic. The last measure will occur 1 year after the placement of the definitive implant restoration.

Secondary Outcomes (3)

  • Implant success

    Assessed at the 12-month follow-up visit.

  • Periimplant bone level

    Radiographs will be obtained at 4 time points: immediately after implant placement, at the session of the provisional prosthesis installation, and at the 6 and 12-month follow-up visits after the delivery of the definitive prosthesis.

  • Condition of the periimplant soft tissues

    15-days, 6- and 12-month follow-up visits after delivery of the definitive prosthesis.

Study Arms (2)

Hydrophilic surface implants

EXPERIMENTAL
Device: Hydrophilic surface implants

Hydrophobic surface implants

ACTIVE COMPARATOR
Device: Hydrophobic surface implants

Interventions

A dental implant with hydrophilic surface will be placed and restored in single-tooh gaps of the posterior region of the mandible or maxilla.

Also known as: Neodent Helix Grand Morse® Acqua
Hydrophilic surface implants

A dental implant with hydrophobic surface will be placed and restored in single-tooh gaps of the posterior region of the mandible or maxilla.

Also known as: Neodent Helix Grand Morse® Neoporos
Hydrophobic surface implants

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Present single or multiple intercalated untreated tooth gaps in the posterior region of the mandible or maxilla;
  • Agree to participate in the study by signing the informed consent form.

You may not qualify if:

  • Unavailability for participation or signs that they could not comply with the schedule of follow-up visits;
  • Presence of general and/or local contraindications that could prevent the surgical procedure for implant placement;
  • Presence of conditions that may interfere with the prognosis, such as current treatment with bisphosphonates or report of use for less than 2 years, presence of rheumatic diseases, among others;
  • Absence of the minimum bone quantity of 8 mm in length and 3.75 mm in diameter for installation of an implant in the tooth gap;
  • Absence of a mesio-distal space of at least 4.6 mm in the single tooth gap required to place the surgical guide;
  • Do not present a mouth opening of at least 12mm required for the proper of the guided surgical kit together with the surgical guide;
  • Do not present a band of keratinized tissue favorable for maintaining peri-implant health.
  • Present motor difficulties that compromise adequate oral hygiene.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Faculty of Dentistry of the Federal University of Goias

Goiânia, Goiás, Brazil

Location

MeSH Terms

Conditions

Tooth LossAnodontia

Condition Hierarchy (Ancestors)

Periodontal DiseasesMouth DiseasesStomatognathic DiseasesTooth DiseasesTooth AbnormalitiesStomatognathic System AbnormalitiesCongenital AbnormalitiesCongenital, Hereditary, and Neonatal Diseases and Abnormalities

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
TRIPLE
Who Masked
PARTICIPANT, INVESTIGATOR, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Full Professor

Study Record Dates

First Submitted

October 15, 2020

First Posted

October 27, 2020

Study Start

April 1, 2021

Primary Completion

September 11, 2023

Study Completion

December 30, 2023

Last Updated

May 10, 2023

Record last verified: 2023-05

Locations